Last quarter (Q ), Brickell Biotech's total revenue was $4.32M, an increase of 2757.62% from the same quarter last year. In Q, Brickell Biotech's net income was $-1.15M. See Brickell Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 4.64M	$ 404.00K	$ 1.82M	$ 7.92M	$ 1.62M	$ 13.82M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 35.17M	$ 40.65M	$ 22.80M	$ 32.38M	$ 21.27M	$ 27.20M
Operating Income	$ -30.53M	$ -40.24M	$ -20.98M	$ -24.47M	$ -19.65M	$ -13.39M
Net Non Operating Interest Income Expense	$ -11.00K	$ -69.00K	$ 0.00	$ -2.10M	-	-
Other Income Expense	$ 663.00K	$ 839.00K	$ 63.00K	$ 2.69M	$ 3.39M	$ 426.00K
Pretax Income	$ -29.88M	$ -39.47M	$ -20.91M	$ -23.88M	$ -16.25M	$ -12.96M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -29.88M	$ -39.47M	$ -20.91M	$ -13.60M	$ -16.25M	$ -12.96M
Basic EPS	$ -4.25	$ -22.05	$ -0.85	$ -4.50	$ -5.18	$ -7.07
Diluted EPS	$ -4.25	$ -22.05	$ -0.85	$ -4.50	$ -5.18	$ -7.07
Basic Average Shares	$ 197.07M	$ 1.78M	$ 24.51M	$ 3.02M	$ 3.12M	$ 1.84M
Diluted Average Shares	$ 197.07M	$ 1.78M	$ 24.51M	$ 3.02M	$ 3.12M	$ 1.84M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 35.17M	$ 40.65M	$ 22.80M	$ 32.38M	$ 21.27M	$ 27.20M
Net Income From Continuing And Discontinued Operation	$ -29.88M	$ -39.47M	$ -20.91M	$ -23.88M	$ -16.25M	$ -12.96M
Normalized Income	$ -30.23M	$ -40.31M	$ -20.98M	$ -26.56M	$ -19.65M	$ -13.39M
Interest Expense	$ 11.00K	$ 69.00K	$ 0.00	$ 2.10M	-	-
EBIT	$ -29.87M	$ -39.41M	$ -20.91M	$ -21.78M	$ -19.65M	$ -13.39M
EBITDA	$ -29.84M	$ -39.38M	$ -20.90M	$ -21.75M	$ -19.50M	$ -12.59M

Currency in USD

Brickell Biotech Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing